Tinavi Medical Technologies Co.,Ltd. (SHA:688277)

SHA:688277 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	277.69	260.2	310.86	211.39	287.11	468.4
Trading Asset Securities	-	-	50.04	40.2	120.63	252.25
Cash & Short-Term Investments	277.69	260.2	360.9	251.59	407.74	720.65
Cash Growth	-10.15%	-27.90%	43.45%	-38.30%	-43.42%	69.39%
Accounts Receivable	121.99	70.96	49.66	35.37	37.52	19.9
Other Receivables	12.42	12.53	9.52	11.85	10.16	6.15
Receivables	134.42	83.49	59.18	47.23	47.68	26.04
Inventory	34.05	31.67	26.23	43.8	37.94	34.77
Prepaid Expenses	-	-	-	2.99	2.75	-
Other Current Assets	30.14	62.61	42.49	27.8	11.3	12.86
Total Current Assets	476.3	437.97	488.8	373.41	507.42	794.32
Property, Plant & Equipment	416.17	422.67	450.35	279.47	112.35	24.37
Long-Term Investments	601.68	596.02	454.34	467.02	265.22	140.9
Other Intangible Assets	32.31	16.34	10.28	6.69	7.61	6.26
Long-Term Accounts Receivable	7.64	8.25	1.65	-	3.41	-
Long-Term Deferred Tax Assets	57.32	54.19	77.87	86	54.16	32.14
Long-Term Deferred Charges	18.3	32.54	13.85	19.38	20.23	4.81
Other Long-Term Assets	124.08	123.73	122.34	174.98	308.64	116.47
Total Assets	1,734	1,692	1,619	1,407	1,279	1,119
Accounts Payable	31.69	27.84	27.79	22.52	9.63	3.96
Accrued Expenses	10.84	35.65	43.17	53.73	37.83	29.46
Short-Term Debt	31.4	25.78	32.81	-	-	-
Current Portion of Long-Term Debt	19.82	18.19	20.68	3.29	-	-
Current Portion of Leases	-	3.94	4.9	33.47	22.59	-
Current Unearned Revenue	42.83	38.66	17.61	32.11	31.56	36.89
Other Current Liabilities	6.44	6.53	20.08	13.26	11.62	10.26
Total Current Liabilities	143.03	156.6	167.04	158.38	113.23	80.57
Long-Term Debt	156.64	150.37	157.75	21.25	-	-
Long-Term Leases	0.36	0.26	3.75	40.41	48.17	-
Long-Term Unearned Revenue	13.98	7.21	4.31	11.8	20.7	4.15
Long-Term Deferred Tax Liabilities	57.58	57.89	42.25	52.37	22.56	1.77
Other Long-Term Liabilities	42	39.24	6.85	5.18	6.82	6.24
Total Liabilities	413.58	411.58	381.95	289.39	211.48	92.73
Common Stock	452.67	449.39	449.39	419.85	419.85	418.44
Additional Paid-In Capital	1,094	1,045	1,031	668.47	670.68	675.18
Retained Earnings	-565.12	-551.92	-467.22	-310.83	-192.12	-117.17
Comprehensive Income & Other	325.46	325.47	224.81	266.2	108.54	19.58
Total Common Equity	1,307	1,268	1,238	1,044	1,007	996.03
Minority Interest	13.12	12.29	-	73.88	60.62	30.52
Shareholders' Equity	1,320	1,280	1,238	1,118	1,068	1,027
Total Liabilities & Equity	1,734	1,692	1,619	1,407	1,279	1,119
Total Debt	208.21	198.54	219.89	98.42	70.76	-
Net Cash (Debt)	69.48	61.65	141.01	153.17	336.98	720.65
Net Cash Growth	-14.21%	-56.28%	-7.94%	-54.55%	-53.24%	69.39%
Net Cash Per Share	0.16	0.14	0.32	0.36	0.80	1.85
Filing Date Shares Outstanding	452.67	449.39	449.39	419.85	419.85	418.44
Total Common Shares Outstanding	452.67	449.39	449.39	419.85	419.85	418.44
Working Capital	333.28	281.37	321.76	215.03	394.19	713.75
Book Value Per Share	2.89	2.82	2.75	2.49	2.40	2.38
Tangible Book Value	1,275	1,252	1,227	1,037	999.34	989.77
Tangible Book Value Per Share	2.82	2.78	2.73	2.47	2.38	2.37
Buildings	-	364.64	360.55	132.86	-	-
Machinery	-	118.95	110.43	108.47	63.3	41.37
Construction In Progress	-	-	10.13	-	-	-

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.